Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	QAW039 450 mg qd Non-atopic	93
Overall Study	STARTED	Placebo Non-atopic	94
Overall Study	STARTED	QAW039 450 mg qd Atopic	51
Overall Study	STARTED	Fluticasone 150 µg Bid Atopic	42
Overall Study	STARTED	Placebo Atopic	54
Overall Study	COMPLETED	QAW039 450 mg qd Non-atopic	82
Overall Study	COMPLETED	Placebo Non-atopic	85
Overall Study	COMPLETED	QAW039 450 mg qd Atopic	49
Overall Study	COMPLETED	Fluticasone 150 µg Bid Atopic	40
Overall Study	COMPLETED	Placebo Atopic	49
Overall Study	NOT COMPLETED	QAW039 450 mg qd Non-atopic	11
Overall Study	NOT COMPLETED	Placebo Non-atopic	9
Overall Study	NOT COMPLETED	QAW039 450 mg qd Atopic	2
Overall Study	NOT COMPLETED	Fluticasone 150 µg Bid Atopic	2
Overall Study	NOT COMPLETED	Placebo Atopic	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01836471/flow